Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0901 Reg QTs
BioCentury & Getty Images

Regulation

Sept. 1 Quick Takes: House committee to subpoena AbbVie on pricing; plus Athenex, Harmony, AZ, BMS, Novo, and cancer trial guidance

Sep 2, 2020 | 1:18 AM GMT

House oversight committee to subpoena AbbVie for

Read the full 402 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE